Search Count: 5
 |
Mmp13 Catalytic Domain Complexed With 4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2007-07-24 Classification: HYDROLASE Ligands: ZN, CA, GG1, HAE |
 |
Crystal Structure Analysis Of The Mmp13 Catalytic Domain In Complex With Specific Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2007-02-27 Classification: HYDROLASE Ligands: ZN, CA, SO4, SP6, HAE |
 |
Fk-506 Binding Protein: Three-Dimensional Structure Of The Complex With The Antagonist L-685,818
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 1994-01-31 Classification: CIS-TRANS ISOMERASE Ligands: 818 |
 |
Fk-506-Binding Protein: Three-Dimensional Structure Of The Complex With The Antagonist L-685,818
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 1994-01-31 Classification: CIS-TRANS ISOMERASE Ligands: FK5 |
 |
Improved Calcineurin Inhibition By Yeast Fkbp12-Drug Complexes. Crystallographic And Functional Analysis
Organism: Saccharomyces cerevisiae
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 1993-10-31 Classification: BINDING PROTEIN Ligands: FK5 |